Digital Photography to Evaluate Dry Eye
Digital Image Based Determination of Ocular Surface Vital Dye Staining
2 other identifiers
observational
60
1 country
1
Brief Summary
Surface eye problems (problems of the cornea and conjunctiva), such as dry eye, are often evaluated using ocular surface staining - the application of a colored dye to the surface of the eye. The physician examines the nature, degree, and pattern of staining on the eye's surface to determine the diagnosis, assess disease severity, and document treatment effects. Grading of ocular surface staining is often used in research studies to measure the response to a treatment or treatment side effects. Therefore, it is critical that the grading methodology be reproducible and sufficiently detailed to detect changes in eye health status. Current evaluation techniques using these dyes are somewhat subjective, however, since they require human assessment and judgment. This study will assess the validity and reliability of digital photography and compare it with standard slit lamp evaluation for analyzing ocular surface dye staining to document surface eye damage in patients with dry eye. Patients 3 years of age and older with dry eye may be eligible for this study. Participants will have the following tests and procedures:
- Visual acuity: (eye chart) test
- Slit lamp evaluation: Examination of the front part of the eye with a special microscope called a slit lamp biomicroscope. Special dyes derived from vegetables are instilled into the eye to stain the surface of the eye where it is dry and damaged. The doctor then determines the extent of staining. The staining will be repeated within one week of the first examination.
- Digital eye photography: Digital photographs of the eye are taken to aid in assessing the extent of dry eye changes. The camera flashes a bright light for each picture. About 5 to 10 pictures are taken for each eye.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2003
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2003
CompletedStudy Start
First participant enrolled
November 14, 2003
CompletedFirst Posted
Study publicly available on registry
November 17, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
September 6, 2007
CompletedJuly 2, 2017
September 6, 2007
November 14, 2003
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Individuals being evaluated or treated for ocular surface disease will be enrolled.
You may not qualify if:
- Patients who cannot hold their eyes open long enough for the photographs to be taken or who has a known allergy to sodium fluorescein or lissamine green will be excluded.
- Children 2 years of age or younger will be excluded since they will not be able to cooperate for slit lamp photography. Dry eye is exceedingly uncommon in this age group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (1)
Kim J. The use of vital dyes in corneal disease. Curr Opin Ophthalmol. 2000 Aug;11(4):241-7. doi: 10.1097/00055735-200008000-00005.
PMID: 10977768BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
November 14, 2003
First Posted
November 17, 2003
Study Start
November 14, 2003
Study Completion
September 6, 2007
Last Updated
July 2, 2017
Record last verified: 2007-09-06